New Post Public Reply Private Reply Replies (0) Message Board ← Newer Older → News Desk 2022 Feb 18, 2019 at 6:45 AM 35 Bionomics Ltd. (BNOEF: OTCQX International) | Further Data Analysis of Bionomics’ Phase 2 Post Traumatic Stress Disorder Trial Shows the Potential for Significant Patient Benefit When Drug Exposure Is Adequate Newer Older
